[ADPCA]) (Harding 1982; Frontali et al. 1992; Ishi-tagmus (62.5%) . Tendon reflexes were normal or kawa et al. 1996) . Neuropathologically, ADPCA shows slightly increased. Extracerebellar symptoms, such as cerebellar cortical atrophy often with degeneration in pyramidal or extrapyramidal tract signs, ophthalmoparthe inferior olivary nucleus (Hoffman et al. 1971 ; Eadie esis, or decreased sensation, were not seen. None of our 1991). Although ADPCA has been well recognized, the patients complained of migraine. Magnetic-resonance SCA5 locus is so far the only gene locus identified for imaging demonstrated restricted atrophy in the cerebelthis subtype (Ranum et al. 1994) . However, our previ-lum in all individuals examined (n Å 35). ous study on eight Japanese families with ADPCA exReliable information on the age at onset was obtained cluded the SCA5 locus, demonstrating that different ge-for 65 individuals, including 5 deceased subjects. The netic mutations cause a similar phenotype (Ishikawa et age-at-onset range was 20-72 years, and the average al. 1996).
{ SD age at onset was 49.5 { 10.7 years. Analysis of To identify the gene(s) for ADPCA, we collected 15 difference in the age at onset in 28 parent-offspring pairs families with ADPCA and initiated a genomewide search revealed that the phenomenon of anticipation was mild for linkage. After screening all autosomes with 243 mi-but statistically significant (age at onset was 2.8 { 7.7 crosatellite markers spaced in Ç15-cM intervals, we years earlier in offspring; P Å .042 by Wilcoxon's test). found evidence that in some of our families ADPCA was
The most striking anticipation in our families was seen linked to chromosome 19p13.1-p13.2. Very recently, in family P3 (age at onset 13.8 { 9.8 years earlier in small expansions of trinucleotide (CAG) repeats in the offspring). In this family, two offspring (P3-8 and alpha1A-voltage-dependent calcium channel (CAC-P3-13) noticed gait ataxia during their 20s, whereas the NL1A4) gene (Ophoff et al. 1996) were identified in mother developed ataxia during her mid 40s. Anticipaeight small American kindreds and were designated tion was also suggested by the observation of an obligate ''SCA6' ' (Zhuchenko et al. 1997) . The chromosomal asymptomatic carrier (P1-15), who was not included in location of the CACNL1A4 gene had been identified in the parent-offspring analysis. This individual was a 60-the 19p13.1 region (Diriong et al. 1995) . We analyzed year-old woman without apparent cerebellar signs. Her this CAG repeat in the SCA6/CACNL1A4 gene and 31-year-old son (P1-22) already showed marked gait found that Japanese families in which ADPCA was ataxia only 2 years after the onset. linked to chromosome 19p also had mild CAG expanAfter informed consent was obtained, blood samples sion. Here we describe our linkage mapping to 19p13.1-were collected from 133 individuals, consisting of 68 p13.2, the mutational profile of the SCA6/CACNL1A4 affected individuals, 57 at-risk family members, and 8 gene, and correlations between the CAG expansion and individuals married into these families. The genes for clinical features in the ADPCA families that we studied.
SCA1-SCA5 and SCA7 were excluded for these families, either by the analysis of the CAG repeats in the Subjects and Methods causative genes or by linkage analysis (data not shown).
ADPCA Families
Markers and Genotyping Fifteen Japanese families were investigated ( fig. 1) .
Two hundred forty-three polymorphic microsatellite Ten of these 15 families were the original residents of markers were selected from either the Généthon map Ibaraki Prefecture, and 2 other families (P13 and P14) (Gyapay et al. 1994) or the Cooperative Human Linkage were from nearby prefectures located in the center of Center (CHLC) database (http: //www.chlc.org), to Honshu, the main island of Japan. The remaining three cover whole autosomes with Ç15-cM intervals. High families were from distant areas: two families (P2 and molecular-weight genomic DNA was extracted and was P10) were from Kyushu and Shikoku, the islands in the amplified by PCR using fluorescein-labeled primers. In southwestern area of Japan, and one family (P8) was brief, 125 ng of genomic DNA was amplified in a from Aomori Prefecture, the northernmost prefecture of 25-ml volume with 2.5 pmol of each primer, 100 mM Honshu. All families were unrelated, and thus our coeach dNTP, 10 mM Tris-HCL (pH 8.4), 50 mM KCl, hort could be considered to represent a certain propor-1.5 mM MgCl2, 0.01% gelatin, and 0.5 units of Taq tion of ADPCA in Japan.
polymerase (Takara). Samples were processed at 94ЊC Clinical features of the 68 affected individuals were for 3 min; for 30 cycles of 94ЊC for 30 s, 55ЊC for 30 summarized as ''pure'' cerebellar ataxia and fulfilled the s, and 72ЊC for 3 min; and finally at 72ЊC for 5 min. diagnostic criteria of ADPCA (Harding 1982; Genotyping was performed by use of an Automated et al. 1992; Ishikawa et al. 1996) . Gait ataxia was invariLaser Fluorescence (A.L.F. TM ) DNA Sequencer II ably the initial symptom and was the chief symptom (Pharmacia Biotech) and was analyzed with Fragment throughout the clinical course. Other symptoms were Manager (Pharmacia Biotech), as described elsewhere cerebellar speech (93.8%), limb ataxia (92.2%), decreased muscle tonus (90.0%), and horizontal gaze nys- (Ishikawa et al. 1996) .
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Figure 1
Fifteen families with ADPCA. Circles and squares denote females and males, respectively; and blackened symbols denote affected individuals. Deceased individuals are denoted by diagonal lines through the symbols. Subjects who were sampled for genetic analysis are indicated by numbers. al. 1984; Terwilliger and Ott 1994) . The disease was scores (3 ú Z max ú 2.5) also were obtained for D19S586, considered to be autosomal dominant with a gene fre-D19S221, and D19S410. Three smaller families (P3, P5, quency of .00001. Recombination fractions (u) in men and P10) also showed supporting data (Z ú 1.0) for and women were assumed to be equal. Since penetrance D19S394, D19S221 and D19S432, whereas six others (P2, of the disease is a function of age, five age-dependent P4, P6, P12, P14, and P15) showed significantly negative penetrance classes were established on the basis of the Z values (i.e., õ02.0). Genetic heterogeneity was proved cumulative age-at-onset profile of the pedigrees: class 1, in D19S394 and D19S221, with significant odds against 0-29 years (3.4%); class 2, 30-39 years (16.9%); class the ''absence of linkage.'' The conditional probabilities of 3, 40-49 years (49.2%); class 4, 50-59 years (86.4%);
linkage suggested this linkage in nine families (P1, P3, P5, and class 5, age ú60 years (95%). For multipoint analy-P7-P11, and P13). The combined pairwise LOD scores sis, the method of maximum Z (Z max ) minus 3 (Z max in these nine families reached Z max values of 9.41 for 0 3) was used to determine the support interval, and the D19S394, 6.62 for D19S221, and 3.97 for D19S432, all distance was calculated by use of the Haldane mapping at u Å .00. function (Terwilliger and Ott 1994) . The heterogeneity Haplotype reconstruction placed the candidate region analysis within the families was performed by use of the within a 16-cM region flanked by D19S586 and program HOMOG, version 3.1 (Ott 1991) .
D19S410: the centromeric boundary was placed at Analysis of CAG Repeats in the SCA6/CACNL1A4
D19S410 by two recombinations in P5 and P10, and Gene the telomeric boundary was placed at D19S586 by three recombinations in P1, P7, and P10. However, haplo-CAG length polymorphism in the SCA6/CACNL1A4 types for the most tightly linked markers (D19S394-gene was determined by use of the S-5 primers described D19S221-D19S432) were different in all families. elsewhere (Zhuchenko et al. 1997) . PCR was performed Multipoint analysis with six markers, D19S586-in a similar manner, with microsatellite markers, except D19S394 -D19S221 -D19S432 -D19S410 -D19S434, that 250 mm of dimethyl sulfoxide (DMSO) was added in these nine families demonstrated Z max Å 10.94 for in each reaction, and the annealing temperature was D19S221 ( fig. 2 ). The support interval was defined raised to 62ЊC. Direct nucleotide-sequence analysis was within a 13.3-cM interval in chromosome 19p13.1-also performed, to determine the accurate number of p13.2; the region between 0.4 cM centromeric to CAG repeats and to determine the presence or absence D19S586 and the location of D19S432. On the other of any interrupting sequences within the CAG repeat.
hand, combined multipoint analysis of six families with-CAG-repeat polymorphism in the Japanese population out linkage (P2, P4, P6, P12, P14, and P15) excluded was determined by examination of 151 healthy volunlinkage (Z õ 02.0) in a 40.3-cM interval spanning the teers who had neither neurological symptoms nor family region between 20 cM telomeric to D19S586 and the history of ataxia. The relationship between the number location of D19S434. (Detailed linkage data are availof CAG repeats and the age at onset was examined by able from the authors.) a simple linear-regression analysis.
Analysis of CAG-Repeat Polymorphism in the Clinical Comparison between Families with SCA6/CACNL1A4 Gene in 19p13.1 Expansions and Families without Expansions
The analysis of CAG-repeat length in neurologically Clinical features of the SCA6 families were compared normal Japanese individuals revealed that the length with those of the non-SCA6 families. Statistical analysis range was 5-20 repeats ( fig. 3) . The distribution pattern of anticipation was performed by Wilcoxon's test, and showed two major peaks; the largest peak was at 13 statistical analysis comparing SCA6 and non-SCA6 famrepeats (allele frequency 42.1%), and the second peak ilies was performed by the Mann-Whitney U-test or by was at 11 repeats (allele frequency 23.2% One of the affected individuals (P13-4) was homozygous for CAG expansions (both alleles 21 repeats). This individual developed ataxic gait at the age of 58 years and showed very mild ataxic symptoms at our examination of him 4 years after onset of his symptoms. His clinical course was indistinguishable from that of his mother (P13-1), who was heterozygous for CAG repeats (18 and 21 repeats). Five asymptomatic individuals (P1-15, P3-9, P8-4, P8-5, and P13-2) were also found to carry the mild expansions. On the basis of haplotype analysis, these individuals were predicted to carry the disease genes. 
D19S221).
The precise locus of the SCA6/CACNL1A4 gene is also indicated.
Correlation between CAG-Repeat Length and Clinical Features in the Eight Families with Expansions P7-P10, and P13) had at least one allele with very mild
The relationship between the length of the expanded expansion. The range in the number of CAG repeats in CAG repeat of affected individuals (n Å 37) and their the expanded (i.e., SCA6) chromosomes was 21-25 (fig. ages at onset is shown in figure 4 . A significant correla-3). The expanded alleles were completely stable within tion coefficient (r) of 0.712 (r 2 Å .507; P õ .001) was each family: one family (P13) had 21 repeats, four fami-
Figure 3
Allele-frequency distributions in 302 normal chromosomes and in 44 SCA6 chromosomes, including those from 5 presymp-
Figure 4
Scattergram of number of CAG repeats in SCA6 chromosomes, versus age at onset in 37 affected individuals. An individual tomatic individuals and 1 homozygous individual. The range in the number of CAG repeats in normal chromosomes was 5-20. The range (P13-4) homozygous for expansion (21 repeats) was excluded from this calculation. A simple linear-regression analysis yielded a signifiin the number of repeats in expanded SCA6 chromosomes was 21-25. Note that there was no repeat-number gap between the two groups.
cant r of 0.712 (r 2 Å .507; P õ .001).
/ 9a2d$$jy49 08-01-97 13:06:34 ajhga UC-AJHG obtained for the age at onset and the repeat length in 4.9 years younger age at onset in offspring; P Å .046). The difference in anticipation between the two groups SCA6 chromosomes. No significant correlation was observed between the repeat length in the normal chromo-(SCA6 vs. non-SCA6) was not statistically significant (P Å .41) . No other features were found that could somes in affected individuals and their ages at onset (data not shown).
differentiate the two groups.
Clinical Comparison between Families with Discussion Expansions and Families without Expansions
Clinical features of eight families with CAG expanWe performed a genomewide search for linkage and found strong evidence for linkage to chromosome 19p13 sion in the SCA6/CACNL1A4 gene (termed the ''SCA6'' families) were compared with those of seven families in the ADPCA families that we studied. This is the first successful linkage study in ADPCA other than SCA5 without such expansion (termed the ''non-SCA6'' families) (table 1). Between the two groups, there were no (Ranum et al. 1994) . Haplotype and multipoint analyses further refined the candidate locus to a 13.3-cM region statistically significant differences in either the age at onset or the duration of illness at examination, and the around D19S221 in 19p13.1-p13.2. Exactly within the candidate locus that we defined, the mild CAG expanclinical features in both groups were almost identical and were summarized as ADPCA. However, the age at sion was identified in the CACNL1A4 gene and was found to segregate with the disease in eight small Amerionset was significantly younger in the SCA6 families than in the non-SCA6 families (SCA6, 45.0 { 10.0 can kindreds with ADCA (i.e., SCA6 [Zhuchenko et al. 1997] ). We examined this CAG repeat in the families years; non-SCA6, 55.9 { 8.2 years; P õ .0001). Analysis of anticipation did not prove significant anticipation in studied and found similar, mild CAG expansions in eight of them. These observations lead us to conclude that in SCA6 families (n Å 21 pairs; 2.1 years younger age at onset in offspring; P Å .31), although great variability some of these Japanese families ADPCA maps to 19p13.1-p13.2 and is strongly associated with mild was noted: the changes in offspring ranged from a 23-years-younger age at onset (i.e., anticipation) to an CAG expansion in the SCA6/CACNL1A4 gene.
The most significant point that we confirmed in this 11-years-older age at onset. Anticipation in the non-SCA6 families was statistically significant (n Å 7 pairs; study is the pathogenic role of CAG-repeat expansions Table 1 Comparison Significantly younger in SCA6 families compared with non-SCA6 families (P õ .0001). e Calculated as age at onset in offspring minus age at onset in parent. f Anticipation was not statistically significant. g Anticipation was proved to be statistically significant (.01 õ P õ .05).
/ 9a2d$$jy49 08-01-97 13:06:34 ajhga UC-AJHG in the SCA6/CACNL1A4 gene. The CAG-repeat expan-However, it should be noted that there was a substantial variation in the age at onset in the same family with the sion in the SCA6/CACNL1A4 gene had three unique and important aspects, compared with other CAG very same expansion: some showed striking ''anticipation'' whereas others exhibited the opposite. According expansions. First is that the size range of the expanded CAG allele was small (21-27 repeats [Zhuchenko et to the statistical analysis ( fig. 4 ), Ç51% (r 2 Å .507) of the variation in age at onset can be accounted for by al. 1997] or 21-25 repeats [present study]) and was completely within the normal range of CAG-repeat the CAG-repeat number, indicating that the remainder of the variation remains to be explained. Although ascernumber in other diseases associated with CAG-repeat expansions (La Spada et al. 1991 ; The Huntington's tainment bias should always be considered in the determination of the age at onset, some other factors-inDisease Collaborative Research Group 1993; Orr et al. 1993; Kawaguchi et al. 1994; Koide et al. 1994 ; Pulst cluding environmental factors-could be present that influence the age at onset in individuals carrying the et al. 1996) . Second is that a single nucleotide deletion or the GrA nucleotide transition in the CACNL1A4 CAG expansion.
When clinical features of the American SCA6 kindred gene is identified as the cause of episodic ataxia (Ophoff et al. 1996) , suggesting that mutation other than tri- (Zhuchenko et al. 1997 ) are compared with those of the Japanese SCA6 families that we studied, several identical nucleotide repeat could be responsible for ADPCA. Third is that the size of normal alleles was continuous features are found. Both groups of families show predominantly cerebellar ataxia with slow disease progresup to 20 repeats and that no gap was observed between the distribution of CAG-repeat numbers on the normal sion (Ishikawa et al. 1996) . The ages at onset are also similar in both groups; onset occurs mostly in the 40s and the SCA6 chromosomes. This is strikingly different from the distributions in SCA1 (Orr et al. 1993), SCA2 and 50s in families with smaller expansions (21-24 repeats), whereas families with relatively larger expan- (Pulst et al. 1996) , or MJD/SCA3 (Takiyama et al. 1995) . No interrupting sequences were seen within the sions (25-27) show a tendency toward earlier onset ( fig.  4) . Restricted cerebellar atrophy, as diagnosed on the CAG-repeat sequences in the SCA6/CACNL1A4 gene, which was another difference from SCA1 (CAT inter-basis of magnetic-resonance imaging, is also a feature common to both groups (Ishikawa et al. 1996) . These ruption [Chung et al. 1993; Jodice et al. 1994] ) and SCA2 (CAA interruption [Pulst et al. 1996] ). At this features are quite similar and could be considered as indicative of ADPCA (Harding 1982; Polo et al. 1991 ; moment, however, we cannot completely exclude the possibility that individuals with larger alleles, such as Frontali et al. 1992) . In addition to the cardinal cerebellar symptoms, mild vibratory and proprioceptive sen-20 repeats, might develop ataxic symptoms in the future or that such alleles are in the condition of premutation.
sory loss, and choking were described in the American SCA6 families. In our series of patients, however, senAlthough the mild CAG expansion in SCA6 appeared to be pathogenic, the number of patients studied was sory dysfunction was not observed. Electrophysiological studies, such as nerve conduction studies or somatosensmall, and the genotype-phenotype correlation was not clear in the original study (Zhuchenko et al. 1997) . In sory evoked potentials, were examined in five patients with 22 or 24 repeats, but all patients were normal. Few the present study, we confirmed that mild CAG expansions similar to those found in the American SCA6 kin-subjects noticed dysphagia-like sensation. However, these patients were ú70 years of age and had long (ú20 dred are present in Japanese families with ADPCA. Furthermore, an inverse correlation between the number of years) durations of illness. It will be important to examine whether these ''extracerebellar'' signs develop in CAG repeats and age at onset was demonstrated, strongly suggesting that CAG expansion, even when SCA6, particularly in patients with larger expansions of CAG repeats or with longer durations of illness. mild, plays a pathogenic role in SCA6.
Another important fact that we observed is that the Finally, our linkage data also showed that there are still several families with ADPCA in Japan that do not CAG expansion in the SCA6/CACNL1A4 gene was completely stable within the SCA6 families that we stud-link to chromosome 19p13. were both excluded for these families. The clinical feaied. This is strikingly different from the situation in other diseases, in which CAG-repeat expansions are often untures of our non-SCA6 families are also those of pure cerebellar ataxia, which is hardly distinguished from stable and the transmission of unstable expansions is thought to be an important, although not the only, mo-that in SCA6 families, except for the average age at onset (table 1) . Therefore, testing SCA6 mutation in patients lecular basis for anticipation (La Spada et al. 1992; Chung et al. 1993; Duyao et al. 1993; Jodice et al. 1994;  clinically diagnosed as ADPCA would be highly important. The present study has indicated the presence of Maciel et al. 1995) . In this context, highly ''stable'' transmission of the expanded CAG repeat appears to be anticipation in non-SCA6 families as well, suggesting that similarly mild CAG expansion may also be present consistent with the fact that the anticipation was not statistically proved in the SCA6 families that we studied. in this group. Further studies are needed to elucidate / 9a2d$$jy49 08-01-97 13:06:34 ajhga UC-AJHG 
